Can a tailored, At-Home exercise plan help breast cancer survivors get moving?

NCT ID NCT07706556

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This pilot study tests a remotely delivered physical activity program designed to help breast cancer survivors increase their weekly exercise. Participants are assigned to either an affect-based or effort-based exercise prescription and receive coaching sessions. Those who are not meeting activity goals at six weeks may be stepped up to additional support. The study aims to see if this adaptive approach is feasible and engaging for survivors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a remotely delivered, adaptive physical activity intervention with affect-based or effort-based exercise prescription
What this could lead to
If successful, this approach could offer a practical, scalable way to help breast cancer survivors become more active and improve their health.
What could go wrong
This is a small pilot study focused on feasibility, not effectiveness. The results may not apply to all survivors, and the intervention may not lead to lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dartmouth-Hitchcock Clinic

    RECRUITING

    Lebanon, New Hampshire, 03756, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.